Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment choices remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Investigate Our Pipeline https://financefeeds.com/tesla-tsla-shares-plunge-over-15/